Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: Comparing the two guidelines in a large Korean cohort

Atherosclerosis

Volumn 240, Issue 1, 2015, Pages 242-249

  Rhee, Eun Jung ^a   Park, Se Eun ^a   Oh, Hyung Geun ^b   Park, Cheol Young ^a   Oh, Ki Won ^a   Park, Sung Woo ^a   Blankstein, Ron ^c   Plutzky, Jorge ^d   Lee, Won Young ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Coronary artery calcification (CAC); Pooled Cohort Equation; Statin

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; FRAMINGHAM RISK SCORE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; ANGIOCARDIOGRAPHY; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DECISION SUPPORT SYSTEM; DYSLIPIDEMIAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; RADIOGRAPHY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SOUTH KOREA; STANDARDS; STATISTICAL MODEL; VASCULAR CALCIFICATION;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; DYSLIPIDEMIAS; ELIGIBILITY DETERMINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR CALCIFICATION;

EID: 84925349083     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.03.006     Document Type: Article

References (38)

1. Go A.S., Mozaffarian D., Roger V.L., American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129:399-410.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III), third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
3. Grundy S.M., Cleeman J.I., Merz C.N., National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004, 110:227-239.
4. Stone N.J., Robinson J., Lichtenstein A.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014, 129(25 Suppl.2):S1-S45.
5. Pencina M.J.1, Navar-Boggan A.M., D'Agostino R.B., et al. Application of new cholesterol guidelines to a population-based sample. N.Engl. J. Med. 2014, 370:1422-1431.
6. Kavousi M., Leening M.J., Nanchen D., et al. Comparison of application of the ACC/AHA guidelines, adult treatment panel III guidelines, and European society of cardiology guidelines for cardiovascular disease prevention in a European cohort. J.Am. Med. Assoc. 2014, 311:1416-1423.
7. Bielak L.F., Rumberger J.A., Sheedy P.F., et al. Probabilistic model for prediction of angiographically defined obstructive coronary artery disease using electron beam computed tomography calcium score strata. Circulation 2000, 102:380-385.
8. Rumberger J.A., Simons D.B., Fitzpatrick L.A., et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995, 92:2157-2162.
9. Detrano R., Guerci A.D., Carr J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N.Engl. J. Med. 2008, 358:1336-1345.
10. Erbel R., Möhlenkamp S., Moebus S., Heinz Nixdorf Recall Study Investigative Group, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J.Am. Coll. Cardiol. 2010, 56:1397-1406.
11. Yu J.H., Yim S.H., Yu S.H., et al. The relationship of body composition and coronary artery calcification in apparently healthy Korean adults. Endocrinol. Metab. 2013, 28:33-40.
12. Hyder J.A., Allison M.A., Wong N., et al. Association of coronary artery and aortic calcium with lumbar bone density: the MESA abdominal aortic calcium study. Am. J. Epidemiol. 2009, 169:186-194.
13. Okwuosa T.M., Greenland P., Ning H., et al. Distribution of coronary artery calcium scores by Framingham 10-year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis) potential implications for coronary risk assessment. J.Am. Coll. Cardiol. 2011, 57:1838-1845.
14. Okwuosa T.M., Greenland P., Ning H., et al. Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham risk score: the CARDIA study. J.Am. Coll. Cardiol. Cardiovasc. Imaging 2012, 5:923-930.
15. Standards of medical care in diabetes-2015: summary of revisions. Diabet. Care 2015, 38(Suppl.l):S4.
16. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
17. Goff D.C., Lloyd-Jones D.M., Bennett G., et al. American College of Cardiology/American Heart Association task force on practice guidelines, 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J.Am. Coll. Cardiol. 2014, 63:2935-2959.
18. Rumberger J.A., Brundage B.H., Rader D.J., et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo. Clin. Proc. 1999, 74:243-252.
19. Pepe M.S. The Statistical Evaluation of Medical Tests for Classification and Prediction 2003, Oxford University Press, New York.
20. Franks P., Tancredi D., Winters P., et al. Cholesterol treatment with statins: who is left out and who makes it to goal?. BMC Health. Serv. Res. 2010, 10:68.
21. Nanchen D., Chiolero A., Cornuz J., et al. Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategies. Am. J. Cardiol. 2009, 103:1089-1095.
22. Nanchen D., Pletcher M.J., Cornuz J., et al. Public health impact of statin prescribing strategies based on JUPITER. Prev. Med. 2011, 52:159-163.
23. Masson W., Lobo M., Huerín M., et al. Use of different scores for cardiovascular risk stratification in primary prevention and their implications in statin indication. Rev. Argent. Cardiol. 2014, 82:456-461.
24. Vaucher J., Marques-Vidal P., Preisig M., et al. Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular disease. Eur. Heart. J. 2014, 35:958-959.
25. Brotons C., Calvo-Bonacho E., Moral I., et al. Impact of the new American and British guidelines on the management and treatment of dyslipidemia in a Spanish working population. Rev. Esp. Cardiol. 2014, 67:906-911.
26. Santos-Gallego C.G., Badimon J.J. Can we stratify cardiovascular risk in Argentina?. Rev. Argent. Cardiol. 2014, 82:449-451.
27. Muntner P., Colantonio L.D., Cushman M., et al. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations. J.Am. Med. Assoc. 2014, 311:1406-1415.
28. Karmali K.N., Goff D.C., Ning H., et al. Asystematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. J.Am. Coll. Cardiol. 2014, 64:959-968.
29. Jee S.H., Jang Y., Oh D.J., et al. Acoronary heart disease prediction model: the Korean Heart Study. BMJ Open 2014, 4:e005025.
30. International Diabetes Federation IDF Diabetes Atlas 2013, International Diabetes Federation, Brussels, Belgium. http://www.idf.org/diabetesatlas, sixth ed.
31. Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus of Korean Diabetes Association, Park IeB., Kim J., Kim D.J., et al. Diabetes epidemics in Korea: reappraise nationwide survey of diabetes "diabetes in Korea 2007". Diabet. Metab. J. 2013, 37:233-239.
32. Bulugahapitiya U., Siyambalapitiya S., Sithole J., et al. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet. Med. 2009, 26:142-148.
33. Johnson K.M., Dowe D.A. Accuracy of statin assignment using the 2013 AHA/ACC cholesterol guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging. J.Am. Coll. Cardiol. 2014, 64:910-919.
34. Bild D.E., Detrano R., Peterson D., et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005, 111:1313-1320.
35. Yamamoto H., Ohashi N., Ishibashi K., et al. Coronary calcium score as a predictor for coronary artery disease and cardiac events in Japanese high-risk patients. Circ. J. 2011, 75:2424-2431.
36. Bhulani N., Khawaja A., Jafferani A., et al. Coronary calcium scoring: are the results comparable to computed tomography coronary angiography for screening coronary artery disease in a South Asian population?. BMC Res. Notes 2013, 6:279.
37. Cook N.R., Ridker P.M. Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study. JAMA Intern. Med. 2014, 174:1964-1971.
38. Nissen S.E. Prevention guidelines: bad process, bad outcome. JAMA Intern. Med. 2014, 174:1972-1973.